Sipp Industries Announces Strategic R&D Agreement With Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma
Sipp Industries與凱路普索藥品達成戰略研發協議,開發納米乳化製劑,針對黑色素瘤治療。
Sipp Industries Announces Strategic R&D Agreement With Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma
Sipp Industries與凱路普索藥品達成戰略研發協議,開發納米乳化製劑,針對黑色素瘤治療。
譯文內容由第三人軟體翻譯。